A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a severe form of age-related macular degeneration (AMD), a common eye disease and ...

A groundbreaking retinal implant system has helped most patients with advanced age-related macular degeneration regain meaningful vision in a clinical trial. The study, published in The New England ...

With three potential blockbuster drugs for retinal disease receiving regulatory approval in 2023, 2024 may feel quiet by comparison for the field. However, retina specialists may feel like they have ...

PITTSBURGH, October 20, 2025 – A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published ...

Several dozen patients with vision loss due to a progressive form of blindness called age-related macular degeneration (AMD) regained some of their central vision thanks to an eye implant paired with ...

For the first time, a vision-restoration effort has achieved successful outcomes in a significant number of patients. Clinical trial findings recently published in the New England Journal of Medicine ...

Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment is available for the so-called atrophic form of this disease. A ...

Pixium Vision has sold the intellectual property and related assets for its Prima Retinal Implants to Science Corporation, a brain-computer interface (BCI) specialist. The deal comes several months ...

An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...